IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.

emavusertib (CA-4948) - Curis, Dr. Reddy’s

http://www.ncbi.nlm.nih.gov/pubmed/37954584

Christina von Roemeling; Han W Tun; Madiha Iqbal; Reinhard von Roemeling; Ricardo D Parrondo

Nov 13, 2023